Al Cunningham

Q: What is Al Cunningham email address?

Email Al Cunningham at al.cunningham@gnarus-systems.com. This email is the most updated Al Cunningham email found in 2026.

Q: How to contact Al Cunningham?

To contact Al Cunningham send an email to al.cunningham@gnarus-systems.com. (updated on November 04, 2024)

President at Gnarus Systems, Inc. | Louisville Metropolitan Area

About Al Cunningham

Al Cunningham, as President of Gnarus Systems, Inc., leads a pioneering team dedicated to advancing the field of computational toxicology and pharmacology. With a robust background in life sciences, Al has been instrumental in the development of the cat-SAR® program, which employs innovative fragment-based structure-activity relationship (SAR) modeling. This program stands out for its ability to generate predictive models from categorical biological response data, offering a reliable and cost-effective approach to assess a wide array of toxicological and pharmacological endpoints.

Under Al's leadership, Gnarus Systems has focused on enhancing virtual screening methodologies, utilizing computational chemistry to streamline the drug discovery process. His expertise in predictive toxicology and virtual ligand-protein interactions has positioned the company at the forefront of anticancer research, where the development of anticancer SAR models has become a key project. Al’s commitment to transparency in modeling ensures that users can fully understand and trust the results generated by the cat-SAR® program, fostering a collaborative environment for researchers and pharmaceutical professionals alike.

With a strong foundation in microbiology, biochemistry, and public health, Al is adept at strategic planning and grant writing, skills that have been vital in navigating the complexities of start-ups within the pharmaceutical industry. His vision for Gnarus Systems is to bridge the gap between computational modeling and practical applications in drug discovery, ultimately contributing to more effective and safer therapeutic options for patients. Through his leadership, Gnarus Systems continues to make significant strides in understanding the intricate relationships between chemical structures and biological responses, solidifying its reputation as a leader in the field.

Al Cunningham Work